First Manhattan
REPL icon

First Manhattan’s Replimune Group REPL Stock Holding History

First Manhattan’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-146,272
Closed -$4.46M – 1602
2021
Q1 		$4.46M Hold
146,272
– – 0.02% 244
2020
Q4 		$5.58M Buy
+146,272
New +$6.09M 0.03% 220

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

First Manhattan's REPL Position: Q2 2021 in Review

First Manhattan sold out of Replimune Group (REPL) in Q2 2021, closing a stake of 146,272 shares — an estimated $4.46M sold.

First Manhattan first reported a position in REPL in Q4 2020 and held it in 2 quarters. The position peaked at $5.58M in Q4 2020. 110 funds tracked by Wall St. Rank hold REPL as of Q2 2021.

  • First Manhattan reported no remaining Replimune Group position as of Q2 2021 after selling out during the quarter.
  • First Manhattan sold 146,272 Replimune Group shares in Q2 2021, an estimated $4.46M.
  • First Manhattan first reported a position in Replimune Group in Q4 2020 and held it in 2 quarters.
  • First Manhattan's Replimune Group position peaked at $5.58M in Q4 2020.
  • 110 funds tracked by Wall St. Rank held Replimune Group as of Q2 2021.

Based on First Manhattan's 13F filing for Q2 2021, filed 16 Aug 2021.